Immunai
Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
HQ: New York, NY, United States
Country: USA

Establishment Year:
2018

Company Stage:
Mature

Estimated Employees:
101 .. 250

Estimated Revenues
$M 38.00

Raised Funding:
$M 295.00

AI Categories: